Neuroscience
Collapsin Response Mediator Protein 2
100%
Neuropathic Pain
57%
Dorsal Root Ganglion
24%
Sensory Neuron
23%
Calcium Channel
21%
Lacosamide
21%
Behavior (Neuroscience)
20%
Sumoylation
18%
Voltage Gated Calcium Channel
17%
Neurotransmitter Release
16%
Allodynia
15%
T-Type Calcium Channel
15%
Neurofibromatosis Type 1
14%
Sodium Channel Nav1.7
13%
Opiate
12%
Nociceptor
12%
Collapsin Response Mediator Protein
11%
Cyclin Dependent Kinase 5
11%
Nociception
10%
Peptide Aptamer
10%
Migraine
10%
Neuroprotection
9%
Hyperalgesia
9%
Aspartic Acid
9%
Alzheimer's Disease
8%
Posttranslational Modification
8%
N-Type Calcium Channel
8%
In Vivo
8%
Voltage Gated Sodium Channel
8%
Potassium Channel
8%
Stereotypic Movement Disorder
7%
Neuropilin-1
7%
Neuropilin 1
7%
Enhancer Region
7%
Neurite Outgrowth
7%
Dendrite
7%
Tibial Nerve
7%
Neuronal Excitability
7%
Sodium Channel
7%
Neuroprotective Agent
7%
Sodium Current
7%
Amino Acid
7%
C-Terminus
6%
Neurodegenerative Disorder
6%
Brain Ischemia
6%
CRISPR
6%
δ -Opioid Receptor
6%
Neurotrauma
6%
Traumatic Brain Injury
6%
Calcitonin
6%
Biochemistry, Genetics and Molecular Biology
Semaphorin
57%
Mediator
56%
Nav1.7
26%
Small Molecule
17%
Electric Potential
17%
Sumoylation
16%
Calcium Channel
14%
Sodium Channel
11%
Posttranslational Modification
10%
Potassium Channel
10%
Minipig
8%
Binding Domain
8%
Surface Property
7%
Mouse
7%
Voltage Gated Calcium Channel
7%
Neurotransmission
7%
Sensory Neuron
6%
Ubiquitin
6%
Wild Type
6%
Intellectual Disability
6%
Cyclin-Dependent Kinase 5
5%
Porcine Model
5%
Opioid-Induced Hyperalgesia
5%
T-Type Calcium Channel
5%
Aptamer
5%
N-Type Calcium Channel
5%
Keyphrases
CRMP2
32%
Neuropathic Pain
17%
Nav1.7
15%
Pain Reduction
10%
Ca2+ Channels
8%
UBC9
8%
SUMOylation
6%
Chronic Pain
6%
Rodents
5%
CaV2.2
5%
Cyclin-dependent Kinase 5 (Cdk5)
5%
Ca2+
5%
Voltage-gated Sodium Channel
5%
Lacosamide
5%
(S)-Lacosamide
5%
Voltage-gated Calcium Channels
5%
Voltage-gated Ion Channels
5%
Pain Behavior
5%
Argentatins
5%
Kv1.3 Channel
5%
Peptide Aptamer
5%
Calmodulin
5%
Small Molecule Targeting
5%